Related Experiment Video
Updated: Jul 6, 2026

06:01
An Electroporation Cytometry Protocol for Live-Cell, Fluorescence Microscopy Using U2 OS Cell Culture
Published on: June 13, 2025
Flow electroporation with pulsed electric fields for purging tumor cells
1Science Research Laboratory, Inc, Somerville, MA, USA.
Methods in Molecular Biology (Clifton, N.J.)
|March 29, 2008
Summary
Pulsed electric fields (PEFs) selectively eliminate larger tumor cells from blood and bone marrow samples, preserving vital progenitor cells. A novel flowing chamber apparatus enables efficient, large-scale tumor purging for cancer therapies.
Area of Science:
- Biotechnology
- Cell Biology
- Cancer Research
Background:
- Electroporation uses pulsed electric fields (PEFs) for transient cell membrane poration and transfection.
- PEFs can selectively eliminate larger cells, including tumor cells, while preserving smaller viable cells.
- This technology is crucial for tumor purging in progenitor-cell transfusions for cancer treatment.
Purpose of the Study:
- To describe a novel flowing chamber apparatus for large-scale tumor purging of clinical progenitor-cell transfusions.
- To overcome challenges in electrical resistance, purging fidelity, and sample volume for effective cell purging.
- To optimize PEF application for efficient and selective cancer cell removal.
Main Methods:
- Design and construction of a flowing chamber pulsed electric field apparatus.
- Optimization of flow conditions for treating large cell volumes (greater than 10^9 cells).
- Application of defined PEF strength to heterogeneous cell mixtures.
Main Results:
- Treatment of over 10^9 cells in 30 minutes under optimized flow conditions.
- Efficient tumor purging of greater than 3 logs achieved for mixtures of tumor and mononuclear cells.
- Preservation and enrichment of viable progenitor cells during the purging process.
Conclusions:
- The flowing chamber PEF apparatus enables efficient, large-scale tumor purging of clinical progenitor-cell transfusions.
- This technique supports high-dose chemotherapy by ensuring purged grafts for autologous stem-cell transplantation.
- PEF technology offers a promising method for improving disease-free survival in hematologic malignancies.

